Skip to main content
PagerDuty, Inc. logo

PagerDuty, Inc. — Investor Relations & Filings

Ticker · PD ISIN · US69553P1003 LEI · 549300U1SB749EDAGH21 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 643 across all filing types
Latest filing 2020-05-04 Proxy Solicitation & In…
Country US United States of America
Listing US PD

About PagerDuty, Inc.

https://www.pagerduty.com/

PagerDuty, Inc. is a cloud computing company that provides a digital operations management platform. Its core offering, the PagerDuty Operations Cloud, is an AI-driven platform designed for real-time incident response and management. The platform serves teams across IT operations, DevOps, security, and customer support by turning digital signals from various tools into actionable insights. Key capabilities include AIOps for noise reduction, automation for accelerating workflows, and end-to-end incident management from detection to resolution and learning. PagerDuty aims to help organizations reduce business risk, build operational resilience, and improve customer experiences by automating critical work and facilitating cross-team collaboration during time-sensitive events.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is identified as a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is labeled as 'Definitive Additional Materials' related to a proxy statement for PagerDuty, Inc. Proxy statements are materials sent to shareholders to provide information and request votes for meetings. The document does not contain financial statements or earnings data, but rather is related to shareholder voting information. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is 2429 characters, which is consistent with a proxy statement or related materials rather than a full annual report or earnings release.
2020-05-04 English
DEF 14A
Proxy Solicitation & Information Statement
2020-05-04 English
PRIMARY DOCUMENT
Director's Dealing
2020-04-22 English
FORM 4 SUBMISSION
Director's Dealing
2020-04-14 English
Mercks-Doravirine-an-Investigational-Non-Nucleoside-Reverse-Transcriptase-Inhibitor-NNRTI-for-the-Treatment-of-HIV-1-Infection-Met-Pr-GHXVQ
Regulatory Filings
2020-04-10 English
PRIMARY DOCUMENT
Director's Dealing
2020-04-04 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.